Immune-Focused Planning
Patients seeking a medical opinion on immune-focused options within a longer-term plan.
Immune-Focused Cell Program · Bangkok
CIK Cell Therapy in Bangkok
CIK stands for Cytokine-Induced Killer cells. The program begins with your own blood cells, which are cultured and activated in a laboratory before being returned intravenously under medical supervision. Suitability requires physician assessment.
Program overview
CIK Cell Therapy at LINNA Longevity
CIK Cell Therapy starts from peripheral blood mononuclear cells (PBMC) collected from your own blood. These cells are isolated and then stimulated in a laboratory environment over approximately 14 to 21 days.
The stimulation process discussed in LINNA's clinical material involves interferon-gamma (IFN-γ), anti-CD3 antibody and interleukin-2 (IL-2). The resulting CIK cells display characteristics associated with both NK cells and T cells.
We describe this program conservatively. It is not a cancer treatment, it does not prevent recurrence, it does not replace chemotherapy or any other standard care, and no destruction of abnormal cells is guaranteed. Whether it is appropriate for you is a medical decision.
What are cytokine-induced killer cells?
PBMC are the immune cells found in circulating blood. When those cells are cultured under specific laboratory conditions with IFN-γ, anti-CD3 antibody and IL-2, a population develops that carries surface and functional characteristics of both natural killer cells and T lymphocytes.
That dual character is why the cells are described as cytokine-induced killer cells. The laboratory work is a controlled process with quality assessment before anything is returned to the patient.
What this means for any individual depends entirely on their medical situation. Our physicians will explain the limits of the current evidence and will decline to proceed where the program is not appropriate.
- Starts from your own peripheral blood mononuclear cells
- Stimulated with IFN-γ, anti-CD3 antibody and IL-2
- Culture period of approximately 14–21 days
- Characteristics associated with both NK cells and T cells
How it works
A clear, medically supervised sequence.
01
Consultation
A physician reviews your health history, current treatment, medication and laboratory findings, and explains the limits of the program.
02
Blood Collection
A blood sample is collected at the clinic for laboratory processing.
03
PBMC Isolation
Peripheral blood mononuclear cells are separated from the sample in the laboratory.
04
Culture & Activation
Cells are cultured and stimulated over approximately 14 to 21 days, then assessed for quality before release.
05
Intravenous Administration
The prepared cells are infused under medical supervision in a private treatment room.
06
Follow-Up
A review appointment is scheduled, with guidance on what to monitor at home.
Why patients consider it
Reasons patients raise with our physicians.
Autologous Cells
Interest in a program built from the patient's own blood cells.
Structured Laboratory Process
Patients who value a defined culture and quality-assessment sequence.
Honest Boundaries
Patients who want the limits explained rather than the benefits oversold.
Coordinated Care
Patients already under specialist care who want their existing treatment respected.
Considered Decision
Patients researching cell therapy who want a conservative, unhurried assessment.
These are topics patients discuss during consultation. They are not promised outcomes, and individual suitability is always determined by a physician.
Medical assessment
Assessment before any treatment decision.
- Physician consultation covering your full medical and treatment history.
- Laboratory testing requested before any collection is scheduled.
- Medication review, including immune-affecting and anticoagulant medication.
- Coordination with your existing treating doctors where relevant.
Who may not be suitable
Individual suitability comes first.
Suitability requires physician assessment. Tell the medical team if any of the following apply to you.
- Acute infection
- Severe autoimmune conditions
- Uncontrolled serious medical conditions
- Use of immunosuppressive medication
- Severe blood disorders
- Abnormal bleeding or clotting problems
- Pregnancy or breastfeeding
- Ongoing intensive cancer treatment under a specialist team
What to expect
Your visit at a glance.
Cell Source
Your own PBMC (autologous)
Laboratory Period
Approximately 14–21 days
Stimulation
IFN-γ, anti-CD3 antibody and IL-2
Administration
Intravenous infusion under medical supervision
Setting
LINNA Clinic Bangkok
Follow-Up
Scheduled review after administration
Before treatment
- Complete the consultation and any laboratory testing requested.
- Bring your full medication, supplement and treatment history.
- Tell the physician about any specialist care you are currently receiving.
- Rest well and keep hydrated before blood collection and before the infusion.
- Plan your schedule around the 14–21 day culture period.
- Raise every remaining question before agreeing to proceed.
After treatment
- Rest for the remainder of the day.
- Maintain hydration and balanced nutrition.
- Avoid strenuous activity for the period advised.
- Follow the individual guidance given by the physician.
- Attend your scheduled follow-up appointment.
- Contact your doctor promptly if fever, chills or any significant unusual symptom occurs.
Why LINNA Longevity
Careful medicine, clearly explained.
Physician-Led Planning
Every program starts with an individual medical review rather than a fixed package.
Transparent Explanations
The team explains what the treatment does, what it does not do, and what remains uncertain.
Monitored Care
Patients are supervised by the medical team during and after treatment.
International Patient Support
Consultation and scheduling can be arranged before you travel to Bangkok.
Price
CIK Cell Therapy
Contact for Current Price
Pricing depends on the laboratory process and plan confirmed after medical assessment. Our Care Team can share current details.
International Patients Welcome
Planning your visit from overseas.
English-Speaking Care Team
LINE & WhatsApp Support
Appointment Coordination Before Arrival
Bangkok Clinic
FAQ
Questions patients ask.
What does CIK stand for?
Cytokine-Induced Killer cells. They are produced by culturing your own peripheral blood mononuclear cells with IFN-γ, anti-CD3 antibody and IL-2.
Is CIK Cell Therapy a cancer treatment?
No. We do not claim that it cures cancer, prevents recurrence, replaces chemotherapy or destroys abnormal cells. It does not replace standard medical treatment.
How long does the laboratory stage take?
Approximately 14 to 21 days, followed by quality assessment before administration.
How many clinic visits are involved?
At least three: consultation, blood collection and infusion, plus a follow-up review.
Who decides whether I can have it?
A physician, after reviewing your history, laboratory results and current treatment. The program is declined where it is not appropriate.
What is the price?
Pricing depends on the laboratory process and the plan agreed after assessment. Contact our Care Team for current details.
Appointments · Bangkok
Discuss CIK Cell Therapy with our medical team
Book a consultation to review your health context, your questions and whether this program is appropriate for you.